Latest filing published 08 Jun 2026 for Vanda Pharmaceuticals Inc..
This profile gathers the share dealings of Richard W. Dugan in Vanda Pharmaceuticals Inc., where the filings describe the role as board member. Between 9 March 2015 and 4 June 2026, the trades on record add up to 21 filings.
On the market, this insider has only sold: 5 sales, €496k in total. Other entries cover 10 share grants and 6 option exercises.
On 8 June 2026 came the latest disclosure, a share grant in Vanda Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations